Home

Auro Laboratories Ltd PE Ratio

Image

Auro Laboratories Ltd

NSE: AUROLABS

PE

44.1

Last updated on: Apr 08, 2025

Key Highlights

  • The P/E Ratio of Auro Laboratories Ltd is 44.1 as of 08 Apr 12:47 PM .
  • The P/E Ratio of Auro Laboratories Ltd changed from 4.8 on March 2020 to 12.9 on March 2024 . This represents a CAGR of 21.86% over 5 years.
  • The Latest Trading Price of Auro Laboratories Ltd is ₹ 257 as of 08 Apr 12:33 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.2. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 159.2. The PE Ratio of Textiles industry is 37.1 in 2024.

Historical P/E Ratio of Auro Laboratories Ltd

No data available

Company Fundamentals for Auro Laboratories Ltd

Image

Auro Laboratories Ltd

NSE: AUROLABS

Share Price

₹ 257

10.65 (4.32%)

stock direction

Last updated on: Apr 08, 2025

Market Price of Auro Laboratories Ltd

1M

1Y

3Y

5Y

Monitoring Auro Laboratories Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Apr 2025246.35
04 Apr 2025251.2
03 Apr 2025256.85
02 Apr 2025245.1
01 Apr 2025241.9
28 Mar 2025230.55
27 Mar 2025231.75
26 Mar 2025238.9
25 Mar 2025239.1
24 Mar 2025240.75

SWOT Analysis Of Auro Laboratories Ltd

Strength

1

che

Weakness

1

che

Opportunity

0

che

Threats

0

che

BlinkX Score for Auro Laboratories Ltd

Asset Value vs Market Value of Auro Laboratories Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Auro Laboratories Ltd153.48
Sun Pharmaceutical Industries Ltd400293
Divis Laboratories Ltd139692
Cipla Ltd111807
Torrent Pharmaceuticals Ltd109399
Mankind Pharma Ltd98130

PE Ratio of Auro Laboratories Ltd Explained

153.48

Market cap

3

Earnings

44.1X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Auro Laboratories Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Auro Laboratories Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Auro Laboratories Ltd

No data available

* All values are in %

About Auro Laboratories Ltd

  • Auro Laboratories Ltd, founded in 1992, has been manufacturing and providing generic Active Pharmaceutical Ingredients (API).
  • Currently, the Company is specializing in producing Anti Diabetics like Metformin HCL. It is the first-line treatment for type 2 diabetes.
  • The Company is headquartered in Mumbai and it has manufacturing facility at Palghar in Maharashtra.
  • The facility has all the required certifications from Indian authorities and European registration organization Since inception, the Company focused on providing quality pharmaceuticals while maintaining high manufacturing standards.
  • Company presently has 1800 MTPA of Metformin HCL manufacturing capacity, with projects underway to expand the capacity to 3600 MTPA. The Company's primary focus was on Anti-Diabetic Drugs, which estimated to be one of the fastest growing therapeutic segments.

Auro Laboratories Ltd News Hub

Auro Laboratories standalone net profit rises 5.63% in the June 2024 quarter

Net profit of Auro Laboratories rose 5.63% to Rs 0.75 crore in the quarter ended June 2024 as agains

Read more

10 Aug 24

Auro Laboratories to announce Quarterly Result

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 9 August 2024 Powe

Read more

01 Aug 24

Auro Laboratories to hold board meeting

Auro Laboratories will hold a meeting of the Board of Directors of the Company on 11 November 2024 P

Read more

06 Nov 24

Auro Laboratories standalone net profit declines 81.73% in the September 2024 quarter

Net profit of Auro Laboratories declined 81.73% to Rs 0.36 crore in the quarter ended September 2024

Read more

12 Nov 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Auro Laboratories Ltd

What is the current PE Ratio of Auro Laboratories Ltd?

The Current PE Ratio of Auro Laboratories Ltd is 44.07 as on 8 Apr 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 8 Apr 2025.

What was the PE Ratio of Auro Laboratories Ltd last year?

The PE Ratio of Auro Laboratories Ltd was 13.94 last year, now the PE ratio is 44.07, showing a year-on-year growth of 216.1%.

What does the PE Ratio of Auro Laboratories Ltd indicate about its stock?

The PE Ratio of Auro Laboratories Ltd is 44.07. This ratio indicates that investors are willing to pay 44.07 times the earnings per share for each share of Auro Laboratories Ltd.

What is the PE Ratio Growth of Auro Laboratories Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Auro Laboratories Ltd grew by 216.1% whereas, the EPS ratio grew by -86.0.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions